Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
- PMID: 16933050
- DOI: 10.1007/s10552-006-0049-z
Body size and composition and prostate cancer risk: systematic review and meta-regression analysis
Abstract
The evidence that measures of obesity and stature are associated with prostate cancer is weak and inconsistent. We performed a systematic review and meta-analysis of the relationship between body mass index (BMI), height, weight, waist circumference and waist-to-hips ratio (WHR) and the risk of prostate cancer. Study-specific dose-response slopes were obtained, and random effects rate ratios (RRs) were computed from linear meta-regression models. We included 55,521 cases identified among 2,818,767 men from 31 cohort studies, and 13,232 cases and 16,317 controls from 25 case-control studies. The overall RR for BMI was 1.05 per 5 kg/m2 increment, 95% CI 1.01-1.08. For studies that reported results by stage of disease, the RRs were stronger for advanced disease (RR 1.12 per 5 kg/m2 increment, 95% CI 1.01-1.23) compared with localized disease (RR 0.96 per 5 kg/m2 increment, 95% CI 0.89-1.03), p = 0.02. Height was also positively associated with risk (RR 1.05 per 10 cm increment, 95% CI 1.02-1.09), but the evidence was weak for weight (RR 1.01 per 10 kg increment, 95% CI 0.97-1.04), waist circumference (RR 1.03 per 10 cm increment, 95% CI 0.99-1.07), and WHR (RR 1.11 per 0.1 unit increment, 95% CI 0.95-1.30). Stronger associations were observed among cohort studies compared with case-control studies for BMI (p = 0.006), height (p < 0.001) and weight (p = 0.02). This meta-analysis indicates that obesity is weakly associated with an increased risk of prostate cancer (particularly advanced stage tumors). While increased stature may also increase risk, there is little evidence for an association with central obesity.
Similar articles
-
Anthropometric factors and ovarian cancer risk: a systematic review and nonlinear dose-response meta-analysis of prospective studies.Int J Cancer. 2015 Apr 15;136(8):1888-98. doi: 10.1002/ijc.29207. Epub 2014 Sep 24. Int J Cancer. 2015. PMID: 25250505
-
Body size and risk of prostate cancer in Jamaican men.Cancer Causes Control. 2010 Jun;21(6):909-17. doi: 10.1007/s10552-010-9520-y. Epub 2010 Feb 16. Cancer Causes Control. 2010. PMID: 20157773
-
Body size across the life course and prostate cancer in the Health Professionals Follow-up Study.Int J Cancer. 2016 Feb 15;138(4):853-65. doi: 10.1002/ijc.29842. Epub 2015 Sep 23. Int J Cancer. 2016. PMID: 26355806 Free PMC article.
-
Systematic review of prostate cancer's association with body size in childhood and young adulthood.Cancer Causes Control. 2008 Oct;19(8):793-803. doi: 10.1007/s10552-008-9142-9. Epub 2008 Mar 18. Cancer Causes Control. 2008. PMID: 18347923 Review.
-
Central obesity and risks of pre- and postmenopausal breast cancer: a dose-response meta-analysis of prospective studies.Obes Rev. 2016 Nov;17(11):1167-1177. doi: 10.1111/obr.12443. Epub 2016 Jul 19. Obes Rev. 2016. PMID: 27432212 Review.
Cited by
-
Obesity and prostate cancer screening, incidence, and mortality in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.J Natl Cancer Inst. 2023 Dec 6;115(12):1506-1514. doi: 10.1093/jnci/djad113. J Natl Cancer Inst. 2023. PMID: 37382561 Free PMC article.
-
Association between body mass index, metabolic syndrome and common urologic conditions: a cross-sectional study using a large multi-institutional database from the United States.Ann Med. 2023 Dec;55(1):2197293. doi: 10.1080/07853890.2023.2197293. Ann Med. 2023. PMID: 37036830 Free PMC article.
-
Pathogenic Role of Adipose Tissue-Derived Mesenchymal Stem Cells in Obesity and Obesity-Related Inflammatory Diseases.Cells. 2023 Jan 17;12(3):348. doi: 10.3390/cells12030348. Cells. 2023. PMID: 36766689 Free PMC article. Review.
-
Targeting lipid metabolism in metastatic prostate cancer.Ther Adv Med Oncol. 2023 Jan 30;15:17588359231152839. doi: 10.1177/17588359231152839. eCollection 2023. Ther Adv Med Oncol. 2023. PMID: 36743527 Free PMC article. Review.
-
Bone Health Management in the Continuum of Prostate Cancer Disease.Cancers (Basel). 2022 Sep 2;14(17):4305. doi: 10.3390/cancers14174305. Cancers (Basel). 2022. PMID: 36077840 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical